Combigan Ophthalmic Solution Available in New Size
Combigan is indicated to reduce elevated intraocular pressure (IOP) in glaucoma or ocular hypertension where adjunctive or replacement therapy is warranted. It combines brimonidine tartrate, an alpha-adrenergic receptor agonist, and timolol maleate, a beta-adrenergic receptor inhibitor. Each of these ingredients decreases elevated intraocular pressure, whether or not associated with glaucoma. Elevated intraocular pressure is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss.
Combigan is already supplied as a 0.2%/0.5% strength solution in 5mL and 10mL bottles.
For more information call (800) 433-8871 or visit Combigan.com.